戴維醫療(300314.SZ):取得變更後的《醫療器械生產許可證》
格隆匯7月4日丨戴維醫療(300314.SZ)公佈,公司因生產經營需要,對生產範圍進行了變更,同時根據《醫療器械生產監督管理辦法》相關規定,對許可證編號進行變更,並於近日取得了由浙江省藥品監督管理局頒發的變更後的《醫療器械生產許可證》。
變更後的生產範圍包括2002年分類目錄:第Ⅱ類:6826-3-光譜輻射治療儀器,6854-0-其他,6854-7-呼吸設備配件,6856-0-其他;第Ⅲ類:6854-0-其他;2017年分類目錄:第Ⅱ類:09-02-温熱(冷)治療設備/器具,09-03-光治療設備,14-06-與非血管內導管配套用體外器械,14-15-病人護理防護用品,08-03-急救設備,08-07-醫用供氣排氣相關設備,07-03-生理參數分析測量設備,07-04-監護設備;第Ⅲ類:08-03-急救設備***
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.